Related Experiment Video
Updated: Jun 1, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Multicentric Castleman's Disease in a Hepatitis C-Positive Intravenous Drug User: A Case Report
D Y Talukder1, S N Delpachitra
1School of Medicine and Dentistry, James Cook University, Townsville QLD 4814, Australia.
Insights
This case report details a rare instance of Castleman's disease in a patient with hepatitis C. Further research is needed to establish optimal treatments for multicentric Castleman's disease, especially in coinfected individuals.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Castleman's disease is a rare lymphoproliferative disorder.
- Hepatitis C coinfection presents unique challenges in diagnosis and management.
- Multicentric Castleman's disease (MCD) requires tailored treatment strategies.
Observation:
- A 46-year-old male with untreated hepatitis C and a history of intravenous drug use presented with severe weight loss, fevers, night sweats, and recurrent infections.
- Clinical examination revealed hepatomegaly, knee effusion, and lymphadenopathy.
- Diagnostic workup identified osteomyelitis and septic arthritis, with negative HIV and HHV-8 testing.
Findings:
- Lymph node biopsy confirmed plasmacytic Castleman's disease.
- Epstein Barr virus and cytomegalovirus reactivity were noted.
- The patient was initiated on rituximab therapy.
Implications:
- Castleman's disease can present atypically, complicating diagnosis.
- Evidence suggests larger studies are necessary to determine the best treatment protocols for MCD, particularly in hepatitis C-positive patients.
- This case highlights the importance of considering rare diagnoses in patients with complex medical histories and coinfections.
Abstract:
Introduction. We report a rare presentation of Castleman's disease in a hepatitis C-positive patient and present a short review of treatments described in other similar case reports and studies. Case Presentation. A 46-year-old male with untreated hepatitis C and a 16-year history of intravenous drug use presented with pleuritic chest pain and bony pain in the knee, hip, and lower back, on a background of unexplained weight loss of 40 kilograms, fevers, night sweats, and repeated infections over the last two years. Examination discovered tender hepatomegaly, a warm right knee effusion, and painless lymphadenopathy. The patient was reactive to Epstein Barr virus and cytomegalovirus; however, HIV and HHV-8 viral testing was negative. Osteomyelitis of vertebrae T8-T11 and septic arthritis of the knee were found on investigation. A lymph node biopsy revealed histology suggestive of plasmacytic Castleman's disease. The patient is to commence rituximab treatment. Conclusion. Castleman's disease continues to present in novel ways, which may lead to difficulties in clinicopathologic diagnosis. A growing body of evidence suggests larger studies are required to determine the best treatment for multicentric Castleman's disease, particularly in patients with a concomitant disease, including hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
